Skip to main content
. 2018 May 21;2018:9756468. doi: 10.1155/2018/9756468

Table 2.

MINORS scores of eligible studies.

Number A B C D E F G H Total
1 [21] 2 0 2 2 0 2 2 1 11
2 [20] 2 2 2 2 0 2 2 1 13
3 [17] 2 0 2 2 0 2 1 1 10
4 [18] 2 0 2 2 0 2 2 0 10
5 [16] 2 0 2 2 0 2 2 1 11
6 [19] 2 0 2 2 0 2 2 1 11
7 [15] 2 0 2 2 0 2 2 1 11
8 [14] 2 2 2 2 0 2 2 0 12
9 [13] 2 0 2 2 0 2 2 0 10

A: a clearly stated aim; B: inclusion of consecutive patients; C: prospective collection of data; D: endpoints appropriate to the aim of the study; E: unbiased assessment of the study endpoint; F: follow-up period appropriate to the aim of the study; G: loss to follow-up less than 5%; H: prospective calculation of the sample size.